Drug development is evolving, and so are we
Algorae is a clinical-stage pharmaceutical company developing transformative solutions for significant undermet medical needs in the community.
Our goal is to accelerate patient access to novel drugs and therapies using the latest technologies and scientific innovations.
Using advanced artificial intelligence computational tools, we can evaluate enormous disparate data banks to both identify therapeutic drug targets and aid our understanding of existing therepeutic assets.
As a public company listed on ASX, and in the United States on OTCQB, we are committed to building long-term value for shareholders by collaborating with world leading organisations for the benefit of our research and development programs.
